Binbin Cheng
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
-
- Immune Cell Function and Interaction
Papers in
-
- Protein Degradation and Inhibitors 10
- Histone Deacetylase Inhibitors Research 5
- Cancer therapeutics and mechanisms 4
- Oncology 20
- Cancer Immunotherapy and Biomarkers 11
- Peptidase Inhibition and Analysis 9
- CAR-T cell therapy research 5
- Co-authors
- Jianjun Chen (30 shared papers)Yichang Ren (9 shared papers)Hao Cao (6 shared papers)Yao Xiao (7 shared papers)Gang Li (2 shared papers)Weien Yuan (1 shared paper)Jing Su (1 shared paper)Yao Liu (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (16 papers)Journal of Medicinal Chemistry (12 papers)Biochemical Pharmacology (1 paper)International Immunopharmacology (1 paper)Bioorganic & Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Binbin Cheng
35 papers receiving 870 citations
Binbin Cheng's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 402
- Immunology 177
- Molecular Biology 431
- Organic Chemistry 179
- Physiology 16
Countries citing papers authored by Binbin Cheng
This map shows the geographic impact of Binbin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Cheng more than expected).
Fields of papers citing papers by Binbin Cheng
This network shows the impact of papers produced by Binbin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Cheng. The network helps show where Binbin Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 92 | |
| 2 | 2021 | 90 | |
| 3 | 2022 | 83 | |
| 4 | 2018 | 81 | |
| 5 | 2020 | 68 | |
| 6 | HDAC-targeting epigenetic modulators for cancer immunotherapy Hit paper breakdown → | 2024 | 67 |
| 7 | 2020 | 57 | |
| 8 | 2020 | 43 | |
| 9 | 2020 | 33 | |
| 10 | 2020 | 31 | |
| 11 | 2019 | 28 | |
| 12 | 2021 | 24 | |
| 13 | 2024 | 17 | |
| 14 | 2024 | 17 | |
| 15 | 2021 | 17 | |
| 16 | 2024 | 15 | |
| 17 | 2024 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2024 | 14 | |
| 20 | 2022 | 13 |
About Binbin Cheng
Binbin Cheng is a scholar working on Molecular Biology, Oncology, Immunology, Organic Chemistry and Cancer Research, having authored 40 papers that have together received 881 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Protein Degradation and Inhibitors (10 papers), Peptidase Inhibition and Analysis (9 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Immunotherapy and Immune Responses (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Oncology (402 citations), Immunology (177 citations), Molecular Biology (431 citations), Organic Chemistry (179 citations) and Physiology (16 citations). Binbin Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Jianjun Chen, Yichang Ren, Hao Cao, Yao Xiao, Gang Li, Weien Yuan, Jing Su, Yao Liu, Yi Xing and Shuanghu Wang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Biochemical Pharmacology, International Immunopharmacology and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.